Logically partners with Rainbow Hospitals to combat health misinformation

Apr 6, 2022

Logically are pleased to announce we've partnered with Rainbow Hospitals, a leading multi-specialty pediatric and obstetrics and gyneacology hospital chain in India.

The new partnership is part of Logically’s healthcare initiative Logically Health, designed to combat health misinformation in India.

Rainbow Hospitals will become an institutional partner in the Logically Health ecosystem, consisting of prominent healthcare experts united in a mission to amplify efforts to combat health misinformation.

Rainbow Hospitals professionals will provide their expertise to Logically’s AI-assisted fact-checking service, providing specialized expertise in the field of pediatrics and women's health, including fertility and maternity health. Logically’s fact-checking process is carried out by combining Logically’s AI and Natural Language Processing technology with one of the world’s largest dedicated fact-checking teams, meaning high quality fact-checking can be achieved at pace and scale.

Ashwin Sivakumar, Senior Advisor for Healthcare and Healthtech at Logically, said:

Logically is excited to be partnering with Rainbow Hospitals to confront dangerous health misinformation in India. Rainbow’s expertise in pediatrics and women’s health is well-known and will prove vital to our efforts to improve patient safety. Having developed advanced AI tools capable of identifying, tracking and counteracting harmful online content at scale, we are confident that together with Rainbow we can make a real difference and help protect the integrity of health information being consumed across the country.”

DISCLAIMER:

Rainbow Children’s Medicare Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its equity shares and has filed a draft red herring prospectus dated December 24, 2021 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the websites of SEBI, Kotak Mahindra Capital Company Limited, IIFL Holdings Limited and J.P. Morgan India Private Limited at www.sebi.gov.in, www.investmentbank.kotak.com, www.iiflcap.com and www.jpmipl.com respectively. Investors should note that investment in equity shares involves a high degree of risk and for details refer to the Red Herring Prospectus, including the section titled “Risk Factors” of the Red Herring Prospectus when available. Potential investors should not rely on the DRHP for any investment decision.

The equity shares offered in the initial public offering have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or any other applicable law of the United States, and, unless so registered, may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws in the United States. Accordingly, the equity shares are being offered and sold (i) within the United States solely to persons who are reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) in transactions exempt from the registrations requirements of the Securities Act, and (ii) outside the United States in “offshore transactions” as defined in and in reliance on Regulation S under the Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. There will be no public offering of equity shares in the United States.